In the BioHarmony Drug Report Database

"Preview" Icon

Alosetron

Lotronex, Aloxi (alosetron) is a small molecule pharmaceutical. Alosetron was first approved as Lotronex on 2000-02-09. It is used to treat abdominal pain, diarrhea, and irritable bowel syndrome in the USA. It has been approved in Europe to treat nausea, neoplasms, and vomiting. It is known to target 5-hydroxytryptamine receptor 3A.

 

Trade Name

 

Aloxi
 

Common Name

 

alosetron
 

ChEMBL ID

 

CHEMBL1110
 

Indication

 

abdominal pain, diarrhea, irritable bowel syndrome, nausea, neoplasms, vomiting
 

Drug Class

 

Serotonin 5-HT3 antagonists

Image (chem structure or protein)

Alosetron structure rendering